THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE

Ischemic stroke (IS) is a severe disease associated with high mortality and persistent disability. Prior IS is related to the drastically increased risk of repeat IS. Antiplatelet therapy is an efficient way to prevent repeat IS. Acetylsalicylic acid, the administration of its enteric-coated formula...

Full description

Bibliographic Details
Main Authors: P. R. Kamchatnov, A. A. Kabanov
Format: Article
Language:Russian
Published: ABV-press 2014-07-01
Series:Klinicist
Subjects:
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/32
_version_ 1797855710642438144
author P. R. Kamchatnov
A. A. Kabanov
author_facet P. R. Kamchatnov
A. A. Kabanov
author_sort P. R. Kamchatnov
collection DOAJ
description Ischemic stroke (IS) is a severe disease associated with high mortality and persistent disability. Prior IS is related to the drastically increased risk of repeat IS. Antiplatelet therapy is an efficient way to prevent repeat IS. Acetylsalicylic acid, the administration of its enteric-coated formulationcan reduce the risk of gastric mucosal lesion, has a special efficacy. The possibilities of using other antiaggregants and indirect anticoagulantsare considered.
first_indexed 2024-04-09T20:27:11Z
format Article
id doaj.art-f3c7f140401145edb1534c0984d2ff7f
institution Directory Open Access Journal
issn 1818-8338
language Russian
last_indexed 2024-04-09T20:27:11Z
publishDate 2014-07-01
publisher ABV-press
record_format Article
series Klinicist
spelling doaj.art-f3c7f140401145edb1534c0984d2ff7f2023-03-30T20:14:07ZrusABV-pressKlinicist1818-83382014-07-0172738010.17650/1818-8338-2013-2-73-8047THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKEP. R. Kamchatnov0A. A. Kabanov1N.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaN.I. Pirogov Russian National Research Medical University, Ministry of Health of RussiaIschemic stroke (IS) is a severe disease associated with high mortality and persistent disability. Prior IS is related to the drastically increased risk of repeat IS. Antiplatelet therapy is an efficient way to prevent repeat IS. Acetylsalicylic acid, the administration of its enteric-coated formulationcan reduce the risk of gastric mucosal lesion, has a special efficacy. The possibilities of using other antiaggregants and indirect anticoagulantsare considered.https://klinitsist.abvpress.ru/Klin/article/view/32ischemic strokesecondary preventionacetylsalicylic acidcardiomagnilwarfarin
spellingShingle P. R. Kamchatnov
A. A. Kabanov
THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
Klinicist
ischemic stroke
secondary prevention
acetylsalicylic acid
cardiomagnil
warfarin
title THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
title_full THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
title_fullStr THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
title_full_unstemmed THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
title_short THE EFFICIENCY AND SAFETY OF SECONDARY PREVENTION OF ISCHEMIC STROKE
title_sort efficiency and safety of secondary prevention of ischemic stroke
topic ischemic stroke
secondary prevention
acetylsalicylic acid
cardiomagnil
warfarin
url https://klinitsist.abvpress.ru/Klin/article/view/32
work_keys_str_mv AT prkamchatnov theefficiencyandsafetyofsecondarypreventionofischemicstroke
AT aakabanov theefficiencyandsafetyofsecondarypreventionofischemicstroke
AT prkamchatnov efficiencyandsafetyofsecondarypreventionofischemicstroke
AT aakabanov efficiencyandsafetyofsecondarypreventionofischemicstroke